The antimicrobial treatment of subacute endometritis: A proof of concept study

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 2, 2004, Pages 305-313

  Eckert, L O ^a   Thwin, S S ^a   Millier, S L ^c   Kiviat, N B ^b   Eschenbach, D A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Endometritis; Pelvic inflammatory disease; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFIXIME;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BLEEDING; CHLAMYDIA TRACHOMATIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRITIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UTERINE CERVICITIS;

EID: 1342281758     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.09.024     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51:48-52.
2. Kiviat NB, Wolner-Hanssen P, Eschenbach DA, Wasserheit JN, Paavonen JA, Bell TA, et al. Endometrial histopathology in patients with culture-proven upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 1990;14:167-75.
3. Wiesenfeld HC, Hillier SL, Krohn MA, Amortegui AA, Heine RP, Landers DV, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002;100:456-63.
4. Ness RB, Keder LM, Soper DE, Amortegui AJ, Gluck J, Wiesenfeld H, et al. Oral contraception and the recognition of endometritis. Am J Obstet Gynecol 1997;176:580-5.
5. Korn AP, Bolan G, Padian N, Ohm-Smith M, Schachter J, Lander DV. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1995;85:387-90.
6. Korn AP, Hessol NA, Padian HS, Bolan GA, Donegan E, Landers DV, et al. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol 1998;187:987-90.
7. Peipert JF, Ness RB, Blume J, Soper DE, Holley R, Randall H, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol 2001;184:856-63.
8. Peipert JF, Ness RB, Soper DE, Bass D. Association of lower genital tract inflammation with objective evidence of endometritis. Infect Dis Obstet Gynecol 2000;8:83-7.
9. Paavonen J, Kiviat N, Brunham RC, Stevens CE, Kuo CC, Stamm WE, et al. Prevalence and manifestation of endometritis among women with cervicitis. Am J Obstet Gynecol 1985;152:280-6.
10. Hillier SL, Kiviat NB, Hawes SE, Hasselquist MB, Wolner-Hanssen P, Eschenbach DA, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996;175:435-41.
11. Eckert LO, Hawes SE, Wolner-Hanssen PK, Kiviat NB, Wasserheit JN, Paavonen JA, et al. Endometritis: the clinical-pathologic syndrome. Am J Obstet Gynecol 2002;186:690-5.
12. Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002;359:765-6.
13. Irwin KL, Moorman AC, O'Sullivan MJ, Sperling R, Koestler ME, Soto I, et al. Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet Gynecol 2000;95:525-34.
14. Simms I, Eastick K, Mallinson H, Thomas K, Gokhale R, Hay P, et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. Sex Trans Infect 2003;79:454-6.
15. Kiviat NB, Paavonen JA, Wolner-Hanssen P, Critchlow CW, Stamm WE, Douglas J, et al. Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol 1990;21:831-7.
16. Wang SP, Graystom JT, Kuo CC, Alexander ER, Holmes KK. Serodiagnosis of Chlamydia trachomatis infection with the micro-immunofluorescence test. In: Holison D, Holmes KK, editors. Nongonococcal urethritis and related infections. Washington (DC): American Society for Microbiology; 1977. p. 237-48.
17. Eschenbach DA, Hillier SL, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestation of bacterial vaginosis. Am J Obstet Gynecol 1988;148:819-28.
18. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
19. Eschenbach DA, Westrom L. Pelvic inflammatory disease. In: Holmes KK, Mardh PA, Sparling PF, Lemon SM, Stamm WE, Piot P, et al, editors. Sexually transmitted diseases. 3rd edition. New York: McGraw-Hill Health Professions Division; 1999. p. 783-809.
20. Patton DL, Sweeney YC, Bohannon NJ, Clark AM, Hughes JP, Clark AM, et al. Effects of doxycycline and anti-inflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques. J Infect Dis 1997;175:648-54.
21. Robert C, Kupper TS. Inflammatory skin diseases, T cells and immune surveillance. N Engl J Med 1999;341:1817-28.
22. Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003;187:650-7.
23. Schwebke JR, Weiss HL. Interrelationship of bacterial vaginosis and cervical inflammation. Sex Transm Dis 2002;29:59-64.
24. Eckert LO, Koutsky LA, Kiviat NM, Krone MR, Stevens CE, Eschenbach DA. The inflammatory Papanicolaou smear: what does this mean? Obstet Gynecol 1995;86:360-6.